Market revenue in 2022 | USD 637.3 million |
Market revenue in 2030 | USD 1,116.0 million |
Growth rate | 7.3% (CAGR from 2022 to 2030) |
Largest segment | Organic acids |
Fastest growing segment | Prebiotics |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Probiotics, Prebiotics, Organic Acids, Phtyogenics |
Key market players worldwide | DSM Firmenich AG, Mitsui & Co Ltd, Lallemand, Beneo, Kemin Industries, DuPont de Nemours Inc, Novonesis AS ADR, Associated British Foods PLC, Novozymes, Evonik Industries AG, Basf SE, Cargill, Archer-Daniels Midland Co, China National Bluestar Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to eubiotics market will help companies and investors design strategic landscapes.
Organic acids was the largest segment with a revenue share of 38.49% in 2022. Horizon Databook has segmented the France eubiotics market based on probiotics, prebiotics, organic acids, phtyogenics covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the France eubiotics market , including forecasts for subscribers. This country databook contains high-level insights into France eubiotics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account